Published Date: 14 Oct 2024
Debate highlights pros and cons of the new recommendation
Read Full NewsFaricimab may stabilize vision, reduce retinal fluid and thickness, and cut treatment burden in difficult-to-treat cases of wet age-related macular degeneration.
Waiting for prior authorization of drugs affects a small portion of patients with age-related macular degeneration, resulting in vision loss.
The U.S. Food and Drug Administration on Monday defended publicizing a lettuce sample later found to be a false positive for cyclospora, saying the reversal does not...
Cyclospora, the parasite behind thousands of suspected U.S. cases of a foodborne illness, has a long incubation period, and samples cannot be cultured in labs, making it...
Sri Lanka's public health services and hospitals are battling the worst outbreak of mosquito-borne dengue in nearly a decade, and turning to the island nation's armed...
Older adults with lower gastrointestinal bleeding present with more severe disease and substantially higher 30-day mortality—yet most deaths stem not from bleeding itself, but from decompensation of underlying chronic conditions.
A prospective multicenter study validates three cerebrospinal fluid biomarkers that may aid diagnosis of suspected primary CNS lymphoma.
1.
Advanced Solid Tumors May Benefit from Investigative Immunotherapy Combo.
2.
CAR T-Cell Therapy in Functional High-Risk Multiple Myeloma
3.
For older LBCL patients, Axi-Cel exhibits durable responses and extends overall survival.
4.
Patients With Melanoma Brain Mets May Fare Better With RT Before Immunotherapy
5.
For older patients with Hodgkin lymphoma, novel regimens produce high response rates.
1.
Navigating the Stages of Thyroid Cancer: A Guide for Patients
2.
How Digital Innovation and AI-Powered Case Studies are Revolutionizing Oncology Education?
3.
Screening Efficacy, Molecular Precision, and Therapeutic Revolutions in Lung Cancer 2025
4.
Unlocking The Causes And Risk Factors Of Breast Cancer
5.
Uncovering the Secrets of CA19-9: A Blood Test for Cancer Diagnosis
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Should We Use DARA Up Front As First-Line Therapy in MM?
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III
4.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
5.
Navigating the Complexities of Ph Negative ALL - Part XIII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation